What is AptarGroup's pharma — goodwill?

AptarGroup (ATR) reported pharma — goodwill of $534.34M in Q1 2026.

What does pharma — goodwill mean?

Represents the premium paid over the fair value of net assets during acquisitions within the pharmaceutical segment. It reflects the value of intangible assets such as brand reputation, customer relationships, and proprietary technology acquired to bolster the segment's market position.

AptarGroup (ATR) Pharma — Goodwill

Screener

Other segment segments

Beauty

$370.16M—

Closures

$168.06M—

Similar metrics at other companies

IEPPharma — Goodwill

$13M0.0%

BTSGPharmacy Solutions — Goodwill

$841.05M0.0%

STZConstellationwinesandspirits — Goodwill

$5.23B+2.1%

DYCommunications — Goodwill

$332.65M—

LENHomebuilding — Goodwill

$3.44B0.0%

COHRIndustrial — Goodwill

$3.25B—

Other financials

Income statement

See full

Revenue$982.9M+10.8%

Gross profit$351.9M+4.6%

Operating income$107.5M-5.2%

Net income$72.7M-7.8%

EPS (diluted)$1.12-4.3%

Balance sheet

See full

Cash & equivalents$225.0M+78.8%

Total debt$1.4B+32.7%

Total equity$2.6B+3.6%

Total assets$5.1B+12.6%

Cash flow

See full

Operating cash flow$118.7M+43.5%

CapEx$65.4M+15.0%

Free cash flow$53.3M+106%

Valuation

See full

Market cap$8.69B-4.7%

Enterprise value$9.9B-2.2%

P/E22.5×-0.8×

P/S2.3×-0.3×

Profitability

See full

Gross margin36.7%-1.6pp

Operating margin12.8%-1.2pp

Net margin10%-0.4pp

FCF margin8.4%-2.1pp

Returns & leverage

See full

Return on equity15%-0.2pp

Debt / equity0.5×+0.1×

Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The source filing: AptarGroup’s 10-Q, filed May 1, 2026.

Filed: May 1, 2026, 11:22 AM EDT
Fiscal quarter: Q1 FY2026
Calendar quarter: Q1 2026
Accession: 0000896622-26-000092

Line item	Pharma	Beauty	Closures	Total
Balance as of December 31, 2025	$538,703	$370,848	$168,347	$1,077,898
Foreign currency exchange effects	(4,364)	(690)	(284)	(5,338)
Balance as of March 31, 2026	$534,339	$370,158	$168,063	$1,072,560

ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)

FAQ

What is AptarGroup's pharma — goodwill?: AptarGroup (ATR) reported pharma — goodwill of $534.34M in Q1 2026.
What does pharma — goodwill mean?: Represents the premium paid over the fair value of net assets during acquisitions within the pharmaceutical segment. It reflects the value of intangible assets such as brand reputation, customer relationships, and proprietary technology acquired to bolster the segment's market position.